about
Agranulocytosis under biotherapy in rheumatoid arthritis: three cases hypothesis of parvovirus B19 involvement in agranulocytosis observed under tocilizumab and rituximab for the treatment of rheumatoid arthritisNucleic acid testing for emerging viral infections.Seroprevalence of parvovirus B19 NS1-specific IgG in B19-infected and uninfected individuals and in infected pregnant women.Parvovirus B19 transmitted by bone marrow.Molecular basis of the globoside-deficient P(k) blood group phenotype. Identification of four inactivating mutations in the UDP-N-acetylgalactosamine: globotriaosylceramide 3-beta-N-acetylgalactosaminyltransferase gene.Pure red cell aplasia.Intravenous immunoglobulin therapy for pure red cell aplasia related to human parvovirus b19 infection: a retrospective study of 10 patients and review of the literature.Genetic heterogeneity at the glycosyltransferase loci underlying the GLOB blood group system and collection.Relation between parvovirus B19 infection and fetal mortality and spontaneous abortion.Detection of Parvovirus B19 Infection in Thalasemic Patients in Isfahan Province, IranZearalenone affects immune-related parameters in lymphoid organs and serum of rats vaccinated with porcine parvovirus vaccine.Glycosphingolipids as receptors for non-enveloped viruses.Pathogen safety of human C1 esterase inhibitor concentrate.Acute human parvovirus b19 infection: cytologic diagnosis.Case-Control Comparison of Enteric Viromes in Captive Rhesus Macaques with Acute or Idiopathic Chronic Diarrhea.Pure Red Cell Aplasia Following Interleukin-2 Therapy.Human parvovirus B19 and blood products.Parvovirus B19 infection. Associated diseases, common and uncommon.Clinical features of 10 fetuses with prenatally diagnosed parvovirus b19 infection and fetal hydrops.Persistent pure red cell aplasia in dicygotic twins with persistent congenital parvovirus B19 infection-remission following high dose intravenous immunoglobulin.The co-existence of pure red cell aplasia and autoimmune haemolytic anaemia in a child with malignant lymphoma.Baculovirus expression of erythrovirus V9 capsids and screening by ELISA: serologic cross-reactivity with erythrovirus B19.A case of parvovirus B19-induced pure red cell aplasia in a child following heart transplant.Effects of oral deoxynivalenol exposure on immune-related parameters in lymphoid organs and serum of mice vaccinated with porcine parvovirus vaccine.Real time PCR reconfirmed three novel clinical associations of parvovirus B19: Non-occlusive bowel gangrene, amegakaryocytic thrombocytopenia & myositis.Rational management approach to pure red cell aplasia.Increase of IL-17, IL-22 and IL-23 serum levels induced by immunoglobulin infusion for Parvovirus-B associated Pure Red Cell Aplasia in a renal transplant recipient.Prediction of fetal anemia in pregnancies with red-cell alloimmunization: comparison of middle cerebral artery peak systolic velocity and amniotic fluid OD450.Prevalence of human erythrovirus B19 DNA in healthy Belgian blood donors and correlation with specific antibodies against structural and non-structural viral proteins.Extra-haematological manifestations related to human parvovirus B19 infection: retrospective study in 25 adults.
P2860
Q28071389-E271DD19-F48F-4F72-A5AE-0AA6684511D3Q30721623-C32C90F6-895B-4B8F-9731-BC7E700F0DE2Q33330672-8D050324-FB3F-4EA6-AC79-ED0F6AB41CA3Q33335447-59BFD596-B719-419E-99DF-CE9E5B4BCBBBQ34129677-CC111EF5-58DB-4A36-B5EB-2B71FCFB3C8AQ34135285-AD202184-F47E-4DDE-9B26-712E6F418CA1Q34317935-A36F4C37-37E1-479C-99EC-51F1561BA7DEQ34320586-10C99259-26E4-4BD9-9142-7E76B400DD28Q35765332-2FC9832E-609D-499A-863F-3B7B3B2434C1Q36528578-56F54B17-1E49-4230-B5A4-987A92F57BDFQ37326426-B14A041B-6526-4EE1-BC88-D340F119E109Q37945203-DE72E51A-A771-4A00-ADD2-04180A16621BQ39380695-4F24AB1C-D1A5-4038-B581-99DB10554732Q39451986-73A607E7-5FFA-4CBA-BA65-1F3F1A1A8950Q40141914-E3A30192-FBAB-4E98-8A67-F034A2BF6FE3Q40482190-8C611E58-D539-400D-800F-E2D5FA503BCDQ40914889-715FAC8B-1727-40C9-977F-818864D03C3CQ41007475-EA92134A-C740-4BC8-8A48-D1003B4EC12FQ41701831-FA918AC1-D6D7-41AF-AF11-9DF8000C9052Q41721092-8F7AFBA2-56F2-465A-866D-1EFFE9ACDF87Q42026580-5B249E90-6B40-43F4-8FF7-C1D66AA096FEQ42052491-65E449BA-318E-4662-BD52-651A6DA146DFQ42236069-24A75D18-E174-4C4A-B1CF-7FC8BCB8FF95Q42273536-A6148592-4330-4B77-87E0-73124E721FD4Q43046072-059B42A6-3EFD-4117-B9F5-D3C132C9C93BQ47584782-C1B3FAC7-8CE0-49D0-B1FB-FD28755A1DC1Q50538619-CD95E6AE-E658-46D8-8175-B7BA31963C34Q50771115-96E98408-1FC3-4001-B1F9-9F0D9EAE4AA3Q52016510-9EE67AC3-C087-42AF-8A39-585C27DF5AAFQ55547413-E7C1ED8C-204C-477D-9204-C7097FE34F52
P2860
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Parvovirus B19 infection and hematopoiesis.
@en
type
label
Parvovirus B19 infection and hematopoiesis.
@en
prefLabel
Parvovirus B19 infection and hematopoiesis.
@en
P1433
P1476
Parvovirus B19 infection and hematopoiesis.
@en
P2093
P304
P356
10.1016/0268-960X(95)90023-3
P577
1995-09-01T00:00:00Z